Table 3 LungLBâ„¢ Test Performance by Participant Characteristic
Category | n | AUC | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|
All Samples (Mayo Clinic Model) | 151 | 0.5182 | 23.4 | 89.7 |
Samples with Available PET Scan | 79 | 0.5674 | 67.2 | .4 |
All Samples (Unweighted) | 151 | 0.7379 | 67.9 | 74.4 |
All Samples (Weighted for Advanced CGACs) | 151 | 0.7834 | 76.8 | 71.8 |
 Nodule Size |  |  |  |  |
  < 2 cm | 83 | 0.8269 | 83.9 | 69.5 |
  ≥ 2 cm | 68 | 0.7049 | 69.1 | 69.2 |
 Nodule Consistency |  |  |  |  |
  Solid | 92 | 0.7215 | 65.2 | 65.2 |
  Subsolid | 41 | 0.8952 | 83.3 | 80.0 |
 Cancer Stage |  |  |  |  |
  I | 76 | 0.7945 | 79.0 | 74.4 |
  II-IV | 31 | 0.6716 | 61.3 | 71.8 |
  Unknown | 5 | 0.7333 | 80.0 | 71.8 |
 Malignant Lesion Type |  |  |  |  |
  Adenocarcinoma | 73 | 0.7875 | 72.6 | 74.4 |
  Squamous Cell Carcinoma | 17 | 0.8250 | 88.2 | 71.8 |
  Small Cell and Neuroendocrine | 17 | 0.7541 | 76.5 | 71.8 |
  Other | 5 | 0.6970 | 60.0 | 69.2 |
 Smoking History |  |  |  |  |
 Ever | 120 | 0.7929 | 76.4 | 71.0 |
 Never | 30 | 0.8075 | 78.3 | 85.7 |